End of Study Transition From Study Drug to Open-Label Vitamin K Antagonist Therapy: The ROCKET AF Experience

Kenneth W Mahaffey, Anne S Hellkamp, Manesh R Patel, Karen L Hannan, Kimberly Schwabe, Christopher C Nessel, Scott D Berkowitz, Jonathan L Halperin, Graeme J Hankey, Richard C Becker, Jonathan P Piccini, Günter Breithardt, Werner Hacke, Daniel E Singer, Robert M Califf, Keith A A Fox

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'End of Study Transition From Study Drug to Open-Label Vitamin K Antagonist Therapy: The ROCKET AF Experience'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science